Pharmacokinetics and effects on plasma retinol concentrations of 13-cis-retinoic acid in melanoma patients.

[1]  M. Walker,et al.  Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. , 1996, Cancer investigation.

[2]  J. Saurat,et al.  Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[3]  R. Lotan,et al.  Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. , 1995, Cancer research.

[4]  G. Rassner,et al.  Anti-proliferative activity of natural interferon-alpha, isotretinoin and their combination varies in different human melanoma cell lines. , 1994, Melanoma research.

[5]  H. Nau,et al.  Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. , 1994, Toxicology and applied pharmacology.

[6]  N. Cascinelli,et al.  Results of adjuvant interferon study In WHO melanoma programme , 1994, The Lancet.

[7]  M. Widschwendter,et al.  Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  F. Formelli,et al.  Retinoids: in vitro interaction with retinol‐binding protein and influence on plasma retinol , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Dennis W. K. Coon.  Diagnosis and Management of Melanoma in Clinical Practice , 1992, Springer London.

[10]  E. Sheridan,et al.  Systemic Treatment of Metastatic Malignant Melanoma , 1992 .

[11]  M. Pizzichetta,et al.  Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. , 1989, Cancer research.

[12]  W. Colburn,et al.  Food Increases the Bioavailability of Isotretinoin , 1983, Journal of clinical pharmacology.

[13]  W. Colburn,et al.  Pharmacokinetics of Isotretinoin Following a Single Oral Dose , 1982, Journal of clinical pharmacology.